课题基金 / 基金详情

CONTROL OF MEMBRANE BINDING AND ONCOGENES BY P21RAS

CONTROL OF MEMBRANE BINDING AND ONCOGENES BY P21RAS
P21RAS 对膜结合和癌基因的控制
批准号:
2094434
负责人:
JANICE E BUSS
金额:
$2.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-05-01 至 1995-02-28

项目摘要

项目成果

JANICE E BUSS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Membrane association appears to be an essential step for transformation by ras proteins; mutated ras proteins which are cytosolic fail to cause transformation. Ras undergoes a series of carboxy terminal modifications which generate the membrane-bound form of protein. Attachment of the fatty acid palmitate was the first C-terminal modification identified, and was presumed to be the major reason that ras associated with membranes. Three additional processing steps have been discovered very recently--removal of the final 3 C-terminal residues, methylation of the newly exposed alpha- carboxyl group, and the quite unusual attachment of an isoprenoid moiety. These modifications, particularly the addition of the C15 (farnesyl) hydrocarbon, have the potential to participate in membrane association of ras. The discovery of these new modifications of ras necessitates a re- evaluation of our ideas about how rats binds to membranes. This application proposes to examine carboxy terminal modifications, with an emphasis on farnesylation, to determine each steps' contribution to membrane binding. The goal is to understand how ras interacts with membranes with the aim of developing means to disrupt this interaction as novel methods to inhibit transformation, not by controlling enzymatic activity, but by spatially regulating access of ras to proteins which trigger or transmit its oncogenic signal. The contribution of farnesylation to membrane binding and transformation will be examined in two ways: by constructing mutant ras genes encoding proteins in which modification is interrupted at each step of the pathway; and by examining the growth of ras-transformed cells in which farnesylation has been inhibited. These studies should provide a clearer understanding of how membrane binding controls ras transforming activity.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Induction of a prenylated 65-kd protein in macrophages by interferon or lipopolysaccharide.
通过干扰素或脂多糖在巨噬细胞中诱导异戊二烯化 65-kd 蛋白。
DOI: 10.1002/jlb.58.5.607
发表时间: 1995
期刊: Journal of leukocyte biology
影响因子: 5.5
作者: [Vestal,DJ, Maki,RA, Buss,JE]
通讯作者: Buss,JE
DOI: 10.1006/abbi.1993.1135
发表时间: 1993-03
期刊: Archives of biochemistry and biophysics
影响因子: 3.9
作者: [H. Rilling;E. Bruenger;L. M. Leining;J. Buss;W. W. Epstein-W.]
通讯作者: H. Rilling;E. Bruenger;L. M. Leining;J. Buss;W. W. Epstein-W.
CONTROL OF MEMBRANE BINDING AND ONCOGENES BY P21RAS
  • 批准号:
    2094433
  • 项目类别:
  • 资助金额:
    $14.46万
  • 财政年份:
    1990
  • 负责人:
    JANICE E BUSS
  • 依托单位:
CONTROL OF MEMBRANE BINDING AND ONCOGENES BY P21RAS
CONTROL OF MEMBRANE BINDING AND ONCOGENES BY P21RAS
CONTROL OF MEMBRANE BINDING AND ONCOGENES BY P21RAS
海外基金